An analysis of the CALLA study shows that ctDNA is detected an average of 5.5 months before radiographic progression.

OSE Immunotherapeutics strengthens Growth Strategy: Accelerates key pillars of Inflammation and Immuno-Oncology Ignites strong momentum in immunology & inflammation pipeline through lusvertikimab ...

Harbinger Health has reported clinical data at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, ...

Minimal residual disease-negativity after treatment in DLBCL strongly correlates with remission and overall survival. However ...

Multicancer early detection tests are revolutionizing cancer screening by using liquid biopsies to screen for multiple ...